Worried that owning up to using the drug could jeopardize their VA benefits -- even if they're participating in a medical marijuana program approved by their state -- veterans have often kept mum
Every state, except Maryland, seeing punishments...some more than others...
Funding for CHIP technically expired Oct. 1. States have been operating their programs with leftover funds provided by the Department of Health and Human Services since then
The penalties have been controversial from the beginning
To many American advocates, Canada's health system sounds like the answer to the United States' challenges
As the nation's bill for drug and genetic tests has climbed to an estimated $8.5 billion a year, there's mounting suspicion among health insurers that some testing may do more to boost profit margins than help treat patients.
Two months past its deadline, Congress has yet to fund the Children's Health Insurance Program
Here are five big ways the tax bill could affect health policy
About 40 percent of the hospitals in the U.S. now buy drugs through the program, according to the 2015 GAO report
As the Trump administration and Republicans in Congress look to scale back Medicaid, many voters and state lawmakers across the country are moving to make it bigger
Wonky as it seems, the center's mission - testing innovations to hold down health care costs while increasing quality - has gotten noticed
It may be a challenge to institute any changes before 2020 but other parts of the proposed rule are more likely to take effect sooner
Laws designed to equalize out-of-pocket costs faced by cancer patients undergoing chemotherapy - whether treated intravenously, with pills or liquid doses - are having mixed results, according to new research
Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and PBMs
The medical deduction, originally created in World War II, is available only to taxpayers whose expenses are above 10 percent of their adjusted gross income
For more than three decades, pharmaceutical and biomedical companies have claimed a 50 percent tax credit for the cost of clinical trials on orphan drugs, or those that treat rare diseases affecting fewer than 200,000 people
These subsidies are different from the tax credits many consumers get, depending on their income, to pay Obamacare premiums
After three years of supersized enrollment growth that peaked in 2015 as a result of most states expanding coverage under the ACA, Medicaid enrollment growth slowed to 2.7 percent nationally in fiscal year 2017
Even if it fails to become law, the deal marks a singular achievement that has been almost completely missing in Congress for the past eight years
Some of Trump's actions could have an immediate effect on the enrollment for 2018 ACA coverage that starts Nov. 1
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: